Evidence map›Paper›PMID 30046129›Full record

ArticleScientific reports2018

Gut Bacterial Microbiota and its Resistome Rapidly Recover to Basal State Levels after Short-term Amoxicillin-Clavulanic Acid Treatment in Healthy Adults.

Chad W MacPherson, Olivier Mathieu, Julien Tremblay, Julie Champagne, André Nantel, Stéphanie-Anne Girard, Thomas A Tompkins

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Antibiotic-perturbed microbiota and the role of probiotics.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Antibiotic perturbations to the gut microbiome.Nature reviews. Microbiology · 2023
    Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chad W MacPhersonLallemand Health Solutions Inc., 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada. cmacpherson@lallemand.com.
Olivier MathieuLallemand Health Solutions Inc., 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada.
Julien TremblayNational Research Council Canada, Energy, Mining and Environment, 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada.
Julie ChampagneNational Research Council Canada, Energy, Mining and Environment, 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada.
André NantelNational Research Council Canada, Genomics, 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada.
Stéphanie-Anne GirardLallemand Health Solutions Inc., 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada.
Thomas A TompkinsLallemand Health Solutions Inc., 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada.
Lallemand (Canada) · CANational Research Council Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical effects of antimicrobials and probiotics in combination have been reported, however, little is known about their impact on gut microbiota and its resistome. In this study 16S rRNA gene amplicon, shotgun metagenomics sequencing and antibiotic resistance (ABR) microarray were used on fecal samples of 70 healthy participants, taken at four time points in probiotic (Lactobacillus rhamnosus R0011 and Lactobacillus helveticus R0052) and placebo groups to profile the gut bacterial microbiota and its resistome following administration of amoxicillin-clavulanic acid for one week. Significant shifts in microbiota family composition caused by the antimicrobial in both groups that included decreases in the proportion of Lachnospiraceae, Coriobacteriaceae and unidentified Clostridiales; and notable increases for the proportion of Enterobacteriaceae, Bacteroidaceae and Porphyromonadaceae compared to baseline levels. Resistome showed a corresponding enrichment of ABR genes compared to baseline from such classes as aminoglycosides and beta-lactams that were linked, by in silico inference, to the enrichment of the family Enterobacteriaceae. Despite perturbations caused by short-term antibiotic treatment, both gut microbiota and resistome showed prompt recovery to baseline levels one week after cessation of the antimicrobial. This rapid recovery may be explained by the hypothesis of community resilience.

Indexed as

MetagenomicsAdultAmoxicillin-Potassium Clavulanate CombinationDrug Resistance, MicrobialFecesFemaleHealthy VolunteersHumansLacticaseibacillus rhamnosusLactobacillus helveticusMaleProbioticsRNA, Ribosomal, 16SAmoxicillin-Potassium Clavulanate CombinationRNA, Ribosomal, 16S

Identifiers

PMID30046129
PMCPMC6060159
OpenAlexW2884262556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.